Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2485)
All Articles published online
|
Publishing Process of This Article
|
Oct 6, 2024 (publication date) through Feb 22, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Giorgio A, De Luca M. Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages. World J Clin Cases 2024; 12(28): 6241-6243 [PMID: 39371556 DOI: 10.12998/wjcc.v12.i28.6241] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Giorgio A, De Luca M. Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages. World J Clin Cases 2024; 12(28): 6241-6243 [PMID: 39371556 DOI: 10.12998/wjcc.v12.i28.6241] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i28/6241.htm |
| Number | Citing Articles |
| 1 |
Jiexin Zhang, Yunya Zhang, Yaru Zhao, Huiyue Shen, Yan Zhao, Hongbo Teng. Compound 17 Inhibits Lung Cancer Progression via Inducing Cellular Apoptosis and Blocking TNF Signaling Pathway Activation. International Journal of Molecular Sciences 2026; 27(4): 1693 doi: 10.3390/ijms27041693
|